Search clinical trials for: Clinical follow up

Total 104242 results

Xi Shan Wang

Recruiting

Huaier Granules for Prevention of Recurrence and Metastasis of Colorectal Cancer Patients Following Radical Surgery

Colorectal Cancer

China
Innocoll
Premier Research Group plc

Recruiting

Safety, Tolerability, PK, and Analgesic Effect of INL-001 in Children Following Open Inguinal Hernia Repair

Postoperative Pain | Inguinal Hernia

United States
Anterogen Co., Ltd.

Recruiting

A Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in ALLO-ASC-CD-101 Clinical Trial

Crohn Disease

Korea, Republic of
National Cancer Institute (NCI)

Recruiting

Long-Term Follow-up of People Undergoing Hematopoietic Stem Cell Transplantation

Hematopoietic Stem Cell Transplantation | Tissue Donors

United States
Kyorin University
Japan Clinical Oncology Group

Recruiting

Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III (RE-GEND)

Recurrence | Glioblastoma | Progression

Japan
National Institute of Neurological Disorders and...

Recruiting

Pathological Basis of MRI Signal Changes in Multiple Sclerosis

Multiple Sclerosis

United States
Kuopio University Hospital

Recruiting

Follow-up Study With Clinical Vitamin D Supplementation Trial on Patients With Depression (DepFuD) (DepFuD)

Depressive Disorder | Depression

Finland
Novartis Pharmaceuticals
University of Pennsylvania

Recruiting

CAR-T Long Term Follow Up (LTFU) Study (PAVO)

Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program

United States, Japan, Australia, Germany, Spain, Belgium, Taiwan, Italy, Canada, Israel, Singapore, United Kingdom, Denmark, Finland, Norway, Austria, Netherlands, France
Institut National de la Santé Et de la Recherche...
IHU-A-ICM, Paris, France

Recruiting

Cohort Study to Identify Predictor Factors of Onset and Progression of Parkinson's Disease (ICEBERG)

Parkinson Disease

France
Center for Biomedical Research, LLC
Provision Center for Proton Therapy

Recruiting

Registry Study for Proton Therapy Clinical Outcomes and Long-Term Follow-up (Registry)

Cancer

United States
Turku University Hospital
University of Turku; Hormos Medical; VTT Technical Research Centre of Finland; The... and other collaborators

Recruiting

ENDOMET - Novel Diagnostic Tools and Treatments for Endometriosis (ENDOMET)

Endometriosis

Finland
National Cancer Institute (NCI)

Recruiting

Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies

Breast Cancer | Lung Cancer | Prostate Cancer | Colon Cancer | Liver Cancer

United States
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants

Graft vs Host Disease | Graft Rejection | Graft-versus-leukemia

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

Evaluation, Treatment, and Follow-up of Patients With Lyme Disease

Lyme Disease

United States
National Cancer Institute (NCI)

Completed

Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-Up Study

Breast Cancer

United States
B. Braun Melsungen AG

Completed

Evaluation of Performance Over Dwell Time and Safety of the Central-venous Catheters Certofix® Paed

Central Venous Catheter

Germany, Italy
National Cancer Institute (NCI)

Enrolling by invitation

Nutrition Intervention Trials in Linxian Follow-up Study

Gastric Cancer | Esophageal Cancer

China
Kite, A Gilead Company

Enrolling by invitation

Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells

Solid and Hematological Malignancies

United States, Netherlands, Japan, Australia, France, Israel, Germany, Canada, United Kingdom
Biogen

Completed

A Study to Evaluate Efficacy, Safety, and Tolerability of EID of Natalizumab (BG00002) in Participants With RRMS Switching From Treatment With Natalizumab SID in Relation to Continued SID Treatment- Followed by Extension Study Comprising SC and IV Natalizumab Administration

Multiple Sclerosis, Relapsing-Remitting

United States, Spain, Canada, Australia, Germany, Italy, United Kingdom, Belgium, Netherlands, France, Israel
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Active, not recruiting

Bintrafusp Alfa Program Rollover Study

Cancer | Lung Cancer

Korea, Republic of, Spain, Germany, Japan, Taiwan, China, Italy, United States, Belgium, Russian Federation, Turkey, Ukraine
Johnson & Johnson Consumer Inc. (J&JCI)

Completed

A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy

Pain

United States
Wake Forest University Health Sciences
Stanford University; University of North Carolina, Chapel Hill

Completed

Elagolix for Fertility Enhancement Clinical Trial (EFFECT)

Endometriosis | Unexplained Infertility

United States
National Cancer Institute (NCI)

Enrolling by invitation

Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies

Melanoma | Adenocarcinoma | Neuroendocrine Tumors | Carcinoma NOS

United States
National Eye Institute (NEI)

Active, not recruiting

Age-Related Eye Disease Study (AREDS) Follow-Up

Age-Related Macular Degeneration | Cataract

United States
National Cancer Institute (NCI)

Enrolling by invitation

Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies

Cervical Intraepithelial Neoplasia | Oropharyngeal Neoplasms | Squamous Intraepithelial Lesions of the Cervix | Cervical Neoplasms | Hematologic Malignacies

United States
University of Edinburgh
NHS Lothian; Department of Health, United Kingdom

Completed

Enhanced CJD Surveillance in the Older Population

Dementia | Prion Disease

United Kingdom
National Institute of Environmental Health Sciences...

Completed

Agricultural Health Study Follow-up

Parkinson's Disease | Asthma

United States
NightstaRx Ltd, a Biogen Company

Enrolling by invitation

Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa (SOLSTICE)

Choroideremia | X-Linked Retinitis Pigmentosa

United States, United Kingdom, Netherlands, Germany, France, Brazil, Canada, Denmark, Finland
National Cancer Institute (NCI)
NRG Oncology

Active, not recruiting

Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone

Endometrial Mixed Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Stage IV Uterine Corpus Cancer AJCC v8 | Endometrial Adenocarcinoma | Endometrioid Adenocarcinoma

United States, Canada
National Cancer Institute (NCI)

Active, not recruiting

Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma

Metastatic Melanoma | Recurrent Melanoma | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma AJCC v8

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

Stage III Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage IIIC Lung Cancer AJCC v8 | Unresectable Lung Non-Small Cell Carcinoma | Recurrent Lung Non-Small Cell Carcinoma

United States, Guam
National Cancer Institute (NCI)

Active, not recruiting

Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study

Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Metastatic Malignant Neoplasm in the Lymph Nodes | Metastatic Malignant Neoplasm in the Soft Tissues | Metastatic Malignant Neoplasm in the Viscera and other conditions

United States, Puerto Rico
National Cancer Institute (NCI)

Enrolling by invitation

Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies

Multiple Myeloma | Hematologic Malignancies | Leukemia, B-cell | Lyphoma, B-Cell

United States
National Cancer Institute (NCI)

Enrolling by invitation

Follow-Up Evaluation for Gene-Therapy-Related Delayed Adverse Events After Participation in Pediatric Oncology Branch Clinical Trials

Solid Tumors | Hematologic Malignancies | Pediatric Cancers

United States
Spark Biomedical, Inc.
Hazelden Betty Ford Foundation

Enrolling by invitation

Clinical Outcomes Following Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention: A Long-term Follow-up Study (RESTOREb)

Opioid Use Disorder | Relapse

United States
Galapagos NV
Gilead Sciences

Completed

Long-term Follow-up Study of GLPG0634 in Active Rheumatoid Arthritis Participants (DARWIN3)

Rheumatoid Arthritis

New Zealand, Belgium, Israel, Chile, Argentina, Colombia, Spain, Australia, Latvia, Poland, Russian Federation, United States, Bulgaria, Czechia, France, Germany, Guatemala, Hungary, Mexico, Moldova, Republic of, Romania, Ukraine
NRG Oncology
National Cancer Institute (NCI)

Active, not recruiting

Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

Stage IIIA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Breast Adenocarcinoma

United States, Canada
National Institute of Allergy and Infectious Diseases...

Enrolling by invitation

Evaluation and Long-Term Follow-up of Patients With Inflammatory Disorders

Inflammation

United States
Eli Lilly and Company
NSABP Foundation Inc

Active, not recruiting

Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer (monarchE)

Breast Cancer

United States, Spain, China, Germany, Canada, Taiwan, United Kingdom, Singapore, Italy, Australia, Japan, Hungary, Russian Federation, India, Belgium, New Zealand, Austria, Saudi Arabia, France, Czechia, Korea, Republic of, Finland, Argentin... and more
Merck Sharp & Dohme LLC
Eisai Inc.

Active, not recruiting

Study of Lenvatinib (MK-7902/E7080) in Combination With Pembrolizumab (MK-3475) Versus Standard of Care in Participants With Metastatic Colorectal Cancer (MK-7902-017/E7080-G000-325/LEAP-017)

Colorectal Neoplasms

United States, Argentina, Australia, Canada, China, Denmark, Germany, Israel, Japan, Korea, Republic of, Russian Federation, Spain, Taiwan, Turkey, United Kingdom
Abbott Medical Devices

Completed

Trifecta™ GT Post Market Clinical Follow-up

Aortic Valve Disease | Aortic Valve Disorder

United States, Canada, Portugal, United Kingdom, Estonia, Germany, Netherlands, Belgium, France, Italy, Poland, Spain
BioProtect

Active, not recruiting

Post Marketing Clinical Follow Up of the BioProtect Balloon Implant System (CLP-10441)

Prostate Cancer

Israel, Netherlands, Portugal, Ireland, Poland
Intellia Therapeutics

Enrolling by invitation

Long-Term Follow-Up (LTFU) of Subjects Treated With NTLA 2002

Hereditary Angioedema

France, New Zealand, United Kingdom, Netherlands
National Institute of Environmental Health Sciences...

Enrolling by invitation

Minipuberty of Infancy and the Timing of Pubertal Development in Adolescence: a Follow-up of the Infant Feeding and Early Development (IFED) Cohort

Puberty

United States
Janssen Research & Development, LLC
Janssen Research & Development, LLC

Active, not recruiting

Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene

X-Linked Retinitis Pigmentosa

United States, Canada, Israel, United Kingdom, Spain, Denmark, France, Belgium, Italy, Netherlands, Switzerland
National Cancer Institute (NCI)

Active, not recruiting

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma

Recurrent Neuroblastoma | Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Stage 4 Neuroblastoma

United States, Canada, Australia, New Zealand, Puerto Rico
Alvimedica

Completed

The Alvision™ Interventional Cardiology Diagnostic Catheter Post Market Clinical Follow-up (PMCF) Study.

Vascular Diseases | Coronary Artery Disease | Coronary Disease

Turkey
Lille Catholic University

Active, not recruiting

Health Data Warehouse on Aortic Insufficiency (EDS-AI)

Heart Valve Diseases | Aortic Insufficiency
Alvimedica

Completed

The INVADER™ Percutaneous Transluminal Coronary Angioplasty (PTCA) Post Market Clinical Follow-up (PMCF) Study

Vascular Diseases | Coronary Artery Disease | Coronary Disease

Turkey
National Cancer Institute (NCI)
NRG Oncology

Active, not recruiting

Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery

Pancreatic Adenocarcinoma | Pancreatic Ductal Adenocarcinoma | Pancreatic Intraductal Papillary-Mucinous Neoplasm | Stage I Pancreatic Cancer AJCC v6 and v7 | Stage II Pancreatic Cancer AJCC v6 and v7

United States, Canada, Israel, Belgium

Search clinical trials for: Clinical follow up

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Montenegro

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations